Sesamolin Protects Mice From Ovariectomized Bone Loss by Inhibiting Osteoclastogenesis and RANKL-Mediated NF-κB and MAPK Signaling Pathways

• Asıl Yazarlar: Xue Yang (Yazar), Jiamin Liang (Yazar), Ziyi Wang (Yazar), Yuangang Su (Yazar), Yunfei Zhan (Yazar), Zuoxing Wu (Yazar), Jing Li (Yazar), Xuedong Li (Yazar), Runfeng Chen (Yazar), Jinmin Zhao (Yazar), Jiake Xu (Yazar), Qian Liu (Yazar), Bo Zhou (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Frontiers Media S.A., 2021-06-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

This article was submitted to Experimental Pharmacology and Drug Discovery, a section of the journal Frontiers in Pharmacology. Postmenopausal osteoporosis (PMOP), which increases the risk of fracture, is the most common bone disease in women. PMOP not only increases the risk of death but also impos...